Cargando…
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Liver fibrosis is an advanced liver disease condition, which could progress to cirrhosis and hepatocellular carcinoma. To date, there is no direct approved antifibrotic therapy, and current treatment is mainly the removal of the causative factor. Transforming growth factor (TGF)-β is a master profib...
Autores principales: | Dewidar, Bedair, Meyer, Christoph, Dooley, Steven, Meindl-Beinker, Nadja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912224/ https://www.ncbi.nlm.nih.gov/pubmed/31718044 http://dx.doi.org/10.3390/cells8111419 |
Ejemplares similares
-
TGF-β1 and TGF-β2 abundance in liver diseases of mice and men
por: Dropmann, Anne, et al.
Publicado: (2016) -
Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage
por: Mogler, Carolin, et al.
Publicado: (2015) -
TGF-β2 silencing to target biliary-derived liver diseases
por: Dropmann, Anne, et al.
Publicado: (2020) -
Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
por: Dzieran, Johanna, et al.
Publicado: (2013) -
Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis
por: Yu, Jun, et al.
Publicado: (2018)